Oaktree Specialty Lending (NASDAQ:OCSL) Given New $10.50 Price Target at JPMorgan Chase & Co.

Oaktree Specialty Lending (NASDAQ:OCSL) had its price objective dropped by JPMorgan Chase & Co. from $13.50 to $10.50 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the credit services provider’s stock. JPMorgan Chase & Co.‘s price objective points to a potential downside of 5.70% from the stock’s current price.

OCSL has been the subject of several other reports. Zacks Research downgraded Oaktree Specialty Lending from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Wall Street Zen upgraded Oaktree Specialty Lending from a “sell” rating to a “hold” rating in a research report on Saturday, February 21st. Lucid Cap Mkts upgraded shares of Oaktree Specialty Lending to a “hold” rating in a report on Monday, December 15th. Weiss Ratings lowered shares of Oaktree Specialty Lending from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 9th. Finally, Wells Fargo & Company dropped their price objective on shares of Oaktree Specialty Lending from $13.00 to $12.00 and set an “equal weight” rating on the stock in a report on Thursday, February 5th. Five equities research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus target price of $12.88.

Oaktree Specialty Lending Trading Down 0.7%

Shares of OCSL stock traded down $0.08 on Friday, reaching $11.14. The company had a trading volume of 654,555 shares, compared to its average volume of 806,008. The stock has a market cap of $980.88 million, a PE ratio of 30.93 and a beta of 0.52. The company has a 50-day moving average of $12.20 and a 200-day moving average of $12.99. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.66. Oaktree Specialty Lending has a 12 month low of $11.08 and a 12 month high of $15.85.

Oaktree Specialty Lending (NASDAQ:OCSL) last announced its quarterly earnings results on Tuesday, February 3rd. The credit services provider reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.03. The company had revenue of $74.48 million during the quarter, compared to analyst estimates of $75.72 million. Oaktree Specialty Lending had a net margin of 10.58% and a return on equity of 9.75%. During the same quarter in the previous year, the business earned $0.54 EPS. On average, equities analysts forecast that Oaktree Specialty Lending will post 2.06 earnings per share for the current year.

Hedge Funds Weigh In On Oaktree Specialty Lending

Large investors have recently modified their holdings of the business. MTM Investment Management LLC bought a new position in shares of Oaktree Specialty Lending in the 2nd quarter valued at about $34,000. Garner Asset Management Corp bought a new stake in Oaktree Specialty Lending during the fourth quarter worth about $38,000. Northwestern Mutual Wealth Management Co. acquired a new position in Oaktree Specialty Lending during the fourth quarter valued at approximately $42,000. Sound Income Strategies LLC bought a new position in Oaktree Specialty Lending in the third quarter valued at approximately $42,000. Finally, Nomura Asset Management Co. Ltd. acquired a new position in shares of Oaktree Specialty Lending during the 2nd quarter worth approximately $46,000. 36.79% of the stock is currently owned by institutional investors and hedge funds.

Oaktree Specialty Lending Company Profile

Oaktree Specialty Lending Corporation (NASDAQ: OCSL) is a closed-end, externally managed specialty finance company structured as a business development company (BDC). Launched in 2014, Oaktree Specialty Lending provides customized debt solutions to U.S. middle-market companies, with a focus on senior secured loans, second-lien financings, mezzanine debt and select equity co-investments. The company’s investment strategy centers on floating-rate instruments designed to offer downside protection and income potential in varying interest rate environments.

The firm’s portfolio spans a diverse array of industries, including healthcare, technology, energy, business services and consumer products.